This paper presents the results of the effects of Melitor (25 mg during two months) on the psychic-emotional state, cerebral hemodynamic and bioelectrical activity of the brain in 30 patients (average age 66.2 ± 3.2 years) with ischemic post-stroke depression. It has been found that this drug possesses a multimodal action which is characterized by the decrease of the level of depression, widening of the range of social-environmental activity, improvement of the cerebral blood circulation and harmonization of the brain electrogenesis. In the patients with right versus left hemisphere stroke, the effect of Melitor on the functional state of the brain was more pronounced. Based on the results obtained in our study, we can recommend Melitor to use it in complex scheme of rehabilitation care of patients of the given nosological category.
Jeong, Y.J., Kim, W.C., Kim, Y.S., Choi, K.W., Son, S.Y. and Jeong, Y.G. (2014) The Relationship between Rehabilitation and Changes in Depression in Stroke Patients. Journal of Physical Therapy Science, 26, 1263-1266.
[3]
Douven, E., Kohler, S., Schievink, S.H.J., van Oostenrugge, R.J., Staals, J., Verhey, F.R.J. and Aalten, P. (2017) Temporal Associations between Fatigue, Depression and Apathy after Stroke: Results of the Cognition and Affect after Stroke: A Prospective Evaluation of Risks Study. Cerebrovascular Diseases, 44, 330-337.
https://doi.org/10.1159/000481577
[4]
Kevin, D., Niedens, M. and Wilson, J. (2013) Treatment Outcomes of a Crisis Intervention Program for Dementia with Severe Psychiatric Complications: The Kansas Bridge Project. The Gerontologist, 53, 102-112.
https://doi.org/10.1093/geront/gns104
[5]
Kuznetsov, V.V. and Glushko, S.F. (2013) Cerebral Hemodynamic in the Patients with Post-Stroke Depression. Psychic Health, 2, 11-17.
[6]
Hackett, M.L., Anderson, C.S. and House, A.O. (2005) Management of Depression after Stroke: A Systematic Review of Pharmacological Therapies. Stroke, 36, 1098-1103.
https://doi.org/10.1161/01.STR.0000162391.27991.9d
[7]
Smulevych, A.B. (2007) Depression at Somatic and Psychic Diseases. Medical Inform Agency, Moscow.
[8]
Kim, J.S. (2016) Post-Stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms. Journal of Stroke, 18, 244-255.
https://doi.org/10.5853/jos.2016.01144
[9]
Wein, A.M., Voznesenskaya, T.G., Golubev, V.L. and Dyukova, G.M. (2007) Depression in Neurologic Practice: Clinic, Diagnosis, Treatment. Medical Inform Agency, Moscow.
[10]
Emerski, E. and Robinson, R. (2000) The Neuropsychiatry of Stroke. Psychosomatics, 41, 5-14. https://doi.org/10.1016/S0033-3182(00)71168-6
[11]
Gainotti, G., Antonucci, G., Marra, C. and Paolucci, S. (2001) Relation between Depression after Stroke, Antidepressant Therapy and Functional Recovery. Journal of Neurology and Neurosurgical Psychiatry, 71, 258-261.
https://doi.org/10.1136/jnnp.71.2.258
[12]
Verdelho, A., Henon, H., Lebert, F., Pasquier, F. and Leys, D. (2004) Depressive Symptoms after Stroke and Relationship with Dementia. A Three-Year Follow-Up Study. Neurology, 62, 905-911.
https://doi.org/10.1212/01.WNL.0000115107.66957.8C
[13]
Kasper, S., Hale, A. and Lemoine, P. (2008) Depression after Stroke. Journal of the European College of Neuropsychopharmacology, 19, 412-413.
https://doi.org/10.1016/S0924-977X(09)70638-8
Annoni, J.M., Staub, F., Bruggimann, L., Gramigna, S. and Bogousslavsky, J. (2006) Emotional Disturbances after Stroke. Clinical Experimental Hypertension Journal, 28, 243-249. https://doi.org/10.1080/10641960600549173
[16]
Geyer, J.D. and Gomez, C.R. (2009) Stroke: A Practical Approach. Lippincott Williams &Wilkins.
[17]
Robinson, R.G. and Spalletta, G. (2010) Poststroke Depression: A Review. Canadian Journal of Psychiatry, 55, 341-349. https://doi.org/10.1177/070674371005500602
[18]
Bartoli, F., Lillia, N., Lax, A., Crocamo, C., Mantero, V., Carra, G., Agostoni, E. and Clerici, M. (2013) Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis. Stroke Research and Treatment, 862-978.
[19]
Kuznetsova and Glushko, S.F. (2012) Therapy of Post-Stroke Depression: Melatoninergic Antidepressants. Health in Ukraine, 2-3.
